Twinrix Dosage Schedule
For adults ≥18 years, administer Twinrix as 1 mL intramuscularly using either the standard 3-dose schedule at 0,1, and 6 months OR the accelerated 4-dose schedule at days 0,7,21-30, followed by a booster at 12 months. 1
Standard Schedule (Preferred for Most Situations)
- Give three 1 mL doses at months 0,1, and 6 for routine immunization when there is no urgency for immediate protection 1
- This schedule provides 99% seroconversion for hepatitis A by month 2 and 84% protection against hepatitis B, with nearly 100% protection after the third dose 2
- Each dose contains 720 EL.U. of hepatitis A antigen and 20 μg of hepatitis B surface antigen 1
Accelerated Schedule (For Rapid Protection)
- Use the 4-dose accelerated regimen (days 0,7,21-30, plus month 12) when patients need protection before travel or imminent exposure 1
- This schedule is specifically designed for travelers departing to endemic regions within 1 month 3
- The accelerated regimen provides similar immunogenicity to monovalent vaccines given concurrently 3
- The standard 4-day grace period does NOT apply to the first 3 doses of the accelerated schedule due to its unique timing 1
Critical Timing Requirements
Minimum Intervals for Standard Schedule
- Minimum 4 weeks between doses 1 and 2 1
- Minimum 8 weeks between doses 2 and 3 1
- Minimum 16 weeks between doses 1 and 3 1
If Schedule is Interrupted
- Never restart the series—simply continue where you left off 1, 4
- Give the next dose as soon as possible while respecting minimum intervals 4
- Doses given ≤4 days before the minimum interval are considered valid for the standard schedule 1
Administration Details
- Inject intramuscularly into the deltoid muscle using a needle length appropriate for the patient's size 1
- Store at 35.6°F-46.4°F (2°C-8°C); do not freeze 1
- Each 1 mL dose is administered from a single-dose vial or prefilled syringe 1
Special Population Considerations
Pregnancy
- Twinrix is safe to use in pregnant women who need both hepatitis A and B protection 1
- This is in contrast to Heplisav-B and PreHevbrio, which lack sufficient pregnancy safety data 1
Hemodialysis and Immunocompromised Patients
- Do not use Twinrix in hemodialysis patients—they require higher-dose single-antigen hepatitis B vaccines (40 μg) 1
- Heplisav-B and PreHevbrio safety has not been established in hemodialysis patients 1
Age Restrictions
- Twinrix is licensed only for adults ≥18 years 1
- For adolescents 11-17 years requiring both vaccines, use separate monovalent vaccines 1
Expected Immune Response
- After 2 doses (month 2): >99% anti-HAV positive, 84% anti-HBs protected 2
- After 3 doses (month 7): 100% anti-HAV positive, 97.6-100% anti-HBs protected 5, 2
- Long-term follow-up shows 100% maintain anti-HAV and >95% maintain anti-HBs at 48 months 2
Common Pitfalls to Avoid
- Do not use Twinrix for hepatitis B vaccination alone—it unnecessarily exposes patients to hepatitis A antigen when not indicated 6
- Do not restart the series if interrupted—this wastes doses and delays protection 1, 4
- Do not give dose 3 before 16 weeks from dose 1, even if 8 weeks have passed since dose 2 1
- Do not apply the 4-day grace period to the accelerated schedule's first 3 doses 1
- Do not use in hemodialysis patients—they need higher-dose single-antigen hepatitis B vaccines 1
When to Choose Twinrix Over Single-Antigen Vaccines
- Use Twinrix when patients need protection against BOTH hepatitis A and B 6
- Specific indications include: international travelers to endemic regions, men who have sex with men at risk for both infections, persons with chronic liver disease requiring both vaccines 6
- Use single-antigen hepatitis B vaccine when only hepatitis B protection is needed 6